Ensho Therapeutics has presented additional data supporting NSHO-101, also referred to as EA1080, as an oral one-time-a-day ...
Up to 40% of patients with inflammatory bowel disease (IBD) experience extraintestinal manifestations (EIMs), with the ...
Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
Hosted on MSN22h
Celltrion booth at inflammatory bowel disease research gatheringCelltrion booth at inflammatory bowel disease research gathering Visitors attend a presentation by South Korean ...
Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease ...
Teva and Sanofi's duvakitug showed promising results in a Phase 2b study for ulcerative colitis and Crohn's disease, with ...
An international team led by researchers at the University of Toronto has found a compound in ginger, called furanodienone ...
It basically kept getting passed off as, like, anxiety or stress since I was meeting someone new and eating new foods...” ...
Major Cause of Inflammatory Bowel Disease Discovered June 5, 2024 — Researchers have discovered a new biological pathway that is a principal driver of inflammatory bowel disease (IBD ...
Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...
Tampa Bay Lightning forward Michael Eyssimont was diagnosed with Crohn's disease eight years ago at the age of 21. Since then, he's found a way to manage the disease with treatment and a strict diet.
A study has shown how data, collected by wearable technology, can identify disease flare-ups up to seven weeks in advance.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results